Evaluate Short-Term Outcomes of abciximab in ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials

Figure 3

Comparison of primary safety outcomes between the abciximab and control groups. (a) Major bleeding, (b) minor bleeding, (c) thrombocytopenia, and (d) transfusion.

(a)

(b)

(c)

(d)